Buscar
Mostrando ítems 1-10 de 344
Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes
(Karger, 2012-10)
Aim: Catecholamines regulate functions of the nervous, neuroendocrine and immune systems. Dopamine may modulate the activity of keratinocytes, which play a role in secreting cytokines and chemokines. The aim of this study ...
Behavioral indices of moderate nigrostriatal 6–hydroxydopamine lesion: a preclinical Parkinson's model.
(1993-02)
Asymmetries in turning and scanning were investigated in rats with different degrees of neostriatal dopamine depletion after unilateral injections of 6-hydroxydopamine into the substantia nigra. Animals with severe lesions, ...
Behavioral indices of moderate nigrostriatal 6–hydroxydopamine lesion: a preclinical Parkinson's model.
(1993-02)
Asymmetries in turning and scanning were investigated in rats with different degrees of neostriatal dopamine depletion after unilateral injections of 6-hydroxydopamine into the substantia nigra. Animals with severe lesions, ...
Synthesis and dopamine receptor binding of dihydrexidine and SKF 38393 catecholamine-based analogues
(2022-01-01)
Dopamine is an important neurotransmitter that regulates numerous essential functions, including cognition and voluntary movement. As such, it serves as an important scaffold for synthesis of novel analogues as part of ...
Dopamine agonists for idiopathic hyperprolactinaemia and prolactinoma in adults
(2018-07-25)
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of dopamine agonists for idiopathic hyperprolactinaemia and prolactinoma in adults.
Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268
(Veterinary and Human Toxicology, 2008-02)
Because glutamate compounds alter the release of dopamine and prolactin, the present study examined whether group II metabotropic receptor agonists, LY 354,740 and LY 379,268, had any direct in vitro action on dopamine D2 ...